• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ATRIUM MEDICAL CORPORATION ADVANTA V12 COVERED STENT; STENT, ILIAC

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ATRIUM MEDICAL CORPORATION ADVANTA V12 COVERED STENT; STENT, ILIAC Back to Search Results
Device Problem Leak/Splash (1354)
Patient Problems Occlusion (1984); Stenosis (2263)
Event Type  Injury  
Manufacturer Narrative
On completion of the investigation, a follow up report will be submitted.
 
Event Description
Article: bosiers, m.E.(2020).Longer bridging stent-grafts in iliac branch endografting does not worsen outcome and expands its applicability, even in concomitant diseased hypogastric arteries.Journal of cardiovascular surgery, 191-5.Purpose: the aim of this study was to analyse the impact of longer bsg compared to the widely used 38mm stent-grafts in terms of reintervention rate and primary patency.Method: a retrospective analysis of collected database of all patients who underwent an endovascular aneurysm repair using an ibd between 2005 and 2015.Conclusion: the use of longer stent-grafts seems not to affect the performance of bsg even in the long run.Per the article adverse events included occlusion, endoleaks and restenosis.
 
Manufacturer Narrative
This complaint is based on information within an article and no specific device information has been provided.As there is insufficient details of an actual device malfunction or adverse event that occurred the complaint cannot be confirmed.A device history record (dhr) review was unable to be performed as the device product part number and lot number was not provided within the article.Conclusion: considering the retrospective single-center design of the study with some intentional heterogeneity between both groups, high technical success rate, high freedom of bsg related event or reintervention at 60 months at both groups and the fact that comparison between the two groups shows no significant difference, one can infer that getinge¿s advanta v12tm balloon expandable covered stents performed as expected.The authors do not attribute development of complications to any particular stent type.
 
Event Description
N/a.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ADVANTA V12 COVERED STENT
Type of Device
STENT, ILIAC
Manufacturer (Section G)
ATRIUM MEDICAL CORPORATION
40 continental blvd
merrimack NH
Manufacturer Contact
lori gosselin
40 continental blvd
merrimack, NH 
MDR Report Key11389315
MDR Text Key233963088
Report Number3011175548-2021-00234
Device Sequence Number1
Product Code NIO
Combination Product (y/n)N
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Literature,Health Professional,Company Representative
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 08/12/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received02/26/2021
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received08/09/2022
Was Device Evaluated by Manufacturer? No
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
-
-